[1]
M. I. Lisan Shidqi, B. Santosa, M. Muslim, and H. Haitami, “Evaluation in Hematology and BCR-ABL Molecular Profiles in Patients with Chronic Myeloid Leukemia Undergoing Tyrosine Kinase Inhibitor Therapy”, Med.Lab.Tech.J., vol. 8, no. 2, pp. 200–208, Dec. 2022.